Microviable Therapeutics SL

Checkout our new GutAlive®!! https://bit.ly/3HCLcUm The unique user-friendly, high-capacity device for stool collection sampling and transport in anaerobic conditions that ensures sample stability, microbiota viability and preserves DNA integrity. #gutalive #microbiome #FMT #gutmicrobiota #anaerobes #stoolcollectiondevice #metagenomics

One of our scientific cofounders, Abelardo Margolles, among the most highly cited researchers by Clarivate another year more! https://lnkd.in/grnCUJsX

Gran día y gran evento celebrando el 40 Aniversario del la SRP - Sociedad Regional de Promoción del Principado de Asturias en un escenario inmejorable como es el Teatro de la Laboral. Son muchos los que lo han hecho posible y allí estaban casi todos. Gracias y a seguir así!!

My pleasure to join this morning Jeffrey Gordon together with other distinguished scientists on this special event. J. Gordon received the International Award Princesa de Asturias in 2023 for his pioneering work on microbiota and health. Today he visited the Dairy Research Institute of Asturias IPLA , a research institute belonging to the National Research Council of Spain CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS. This is the institution where I did my PhD and where great science have been developed over the last years related to microbiome, probiotics, humanhealth as well as dairy products. Great discussions and great vibes!!

Gut microbes may help overcome immunotherapy resistance in gastrointestinal cancer

Hoy Noelia Martinez Alvarez y yo estamos en FARMAFORUM 2024 aportando nuestra experiencia desde Microviable Therapeutics SL en la financiación de empresas biotecnológicas. Gracias por invitarnos a participar en este foro de la industria farmacéutica tan relevante para el sector. #farmaforum #biotech #inversión

Claudio Hidalgo Cantabrana y Noelia Martinez Alvarez están hoy en FARMAFORUM 2024, la feria por excelencia de la industria farmacéutica, contribuyendo con su experiencia en la financión de empresas biotecnológicas.

Microviable Therapeutics SL announced today the appointment of Mehdi Chouikh Skalli as Chief Financial Officer. https://lnkd.in/dz-kPpNv Mehdi Chouikh has more than 20 years of experience in strategic management and financial direction, with a track record of success managing top class companies from conception to company acquisitions. Mehdi has been an entrepreneur with the incorporation of several companies successfully, and he is also an investor in a large number of companies from various sectors including biotech. Mehdi is a Telecommunications Engineer (2002, University of Málaga) with a Master in Management of Biotech Companies (2010, ESESA). “I am thrilled to welcome Mehdi Chouikh into the executive team”, said Claudio Hidalgo Cantabrana, Ph.D., co-founder and CEO of Microviable. “The expertise Mehdi provides is crucial for our next steps of growth, including financial strategy and investor relationship”. #microviabletherapeutics #team #microbiome #biotech

🌍 World Cancer Research Day: Exploring Microbiome-Based Cancer Therapies 🌍 https://lnkd.in/eUWd8S67 On September 24th, we join the global community in recognizing World Cancer Research Day (WCRD)—an international movement dedicated to highlighting the critical role of cancer research in driving breakthroughs for cancer control and treatment. The progress being made in #microbiome research offers a new frontier of hope, bringing us closer to tailored treatments that enhance patients' responses to cancer therapies. That is why at Microviable Therapeutics SL we investigate the relationship between microbiota and cancer, with the firm intention of developing new drugs to help prevent and treat this complex disease. Let’s continue to support the incredible efforts of researchers worldwide who are pushing the boundaries of cancer treatment. 🌟 #WorldCancerResearchDay #CancerResearch #MicrobiomeTherapies #InnovativeCancerTreatment #HopeForACure

A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation. https://lnkd.in/dEZQdbBN NATURE Ziqi Ma, Tao Zuo, Norbert Frey & Ashraf Rangrez In this narrative review, the authors integrate the knowledge and insights from various fields, including anatomy, physiology, immunology, histology, genetics, and evolution, to propose a systematic framework. It introduces key concepts such as the ‘innate and adaptive genomes’, which enhance genetic and evolutionary comprehension of the human genome. The ‘germ-free syndrome’ challenges the traditional ‘microbes as pathogens’ view, advocating for the necessity of microbes for health. The ‘slave tissue’ concept underscores the symbiotic intricacies between human tissues and their microbial counterparts, highlighting the dynamic health implications of microbial interactions. ‘Acquired microbial immunity’ positions the microbiome as an adjunct to human immune systems, providing a rationale for probiotic therapies and prudent antibiotic use. The ‘homeostatic reprogramming hypothesis’ integrates the microbiome into the internal environment theory, potentially explaining the change in homeostatic indicators post-industrialization. The ‘cell-microbe co-ecology model’ elucidates the symbiotic regulation affecting cellular balance, while the ‘meta-host model’ broadens the host definition to include symbiotic microbes. The ‘health-illness conversion model’ encapsulates the innate and adaptive genomes’ interplay and dysbiosis patterns. The aim here is to provide a more focused and coherent understanding of microbiome and highlight future research avenues that could lead to a more effective and efficient healthcare system. #microbiome #humanhealth #microbes #microbiota #hostmicrobiomeinteractions